Tag: Cystoid macular edema

Cystoid macular edema (CME) after cataract surgery can occur in up to 70% of cases, though most resolve without intervention [1.3.5]. For those who need treatment, an important question is: what are the eye injections for cystoid macular edema?

While cystoid macular edema (CME) can arise from many causes, the FDA approval for the dexamethasone implant OZURDEX is limited to specific underlying conditions. The biodegradable OZURDEX implant is an important tool in treating retinal swelling, but its official use case is narrower than its clinical application suggests.

The prevalence of glaucoma and cataracts, both common conditions in older adults, often means patients are treated for both. This overlapping demographic has naturally raised questions about whether one condition or its treatment impacts the other, specifically, **does latanoprost affect cataracts** or the recovery from surgery.

While letrozole is a vital medication for many postmenopausal breast cancer patients, evidence from medical literature and case reports confirms that it can, in rare instances, cause various ocular side effects. These issues, which range from common dry eye syndrome to more serious retinal conditions, are important for patients and healthcare providers to monitor.

Cases of drug-related macular edema (ME) have shown an upward trend in recent years, with over 1,800 reports filed with the FDA between 2004 and 2024. Understanding **what drugs cause macular edema?** is crucial for patients and healthcare providers, as this serious retinal swelling can lead to vision loss if not addressed promptly.